Bank of Nova Scotia
TXG icon

Bank of Nova Scotia’s 10x Genomics TXG Stock Holding History

Bank of Nova Scotia’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-328,600
Closed -$3.81M – 1119
2025
Q2 		$3.81M Buy
+328,600
New +$3M 0.01% 562
2023
Q1 		– Sell
-133,156
Closed -$4.85M – 1223
2022
Q4 		$4.85M Buy
+133,156
New +$4.35M 0.01% 484
2020
Q4 		– Sell
-60,197
Closed -$7.5M – 1063
2020
Q3 		$7.5M Buy
+60,197
New +$6.32M 0.02% 399

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of Nova Scotia's TXG Position: Q3 2025 in Review

Bank of Nova Scotia sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 328,600 shares — an estimated $3.81M sold.

Bank of Nova Scotia first reported a position in TXG in Q3 2020 and held it in 3 quarters. The position peaked at $7.5M in Q3 2020. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • Bank of Nova Scotia reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
  • Bank of Nova Scotia sold 328,600 10x Genomics shares in Q3 2025, an estimated $3.81M.
  • Bank of Nova Scotia first reported a position in 10x Genomics in Q3 2020 and held it in 3 quarters.
  • Bank of Nova Scotia's 10x Genomics position peaked at $7.5M in Q3 2020.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on Bank of Nova Scotia's 13F filing for Q3 2025, filed 14 Nov 2025.